IN BRIEF: BioPharma Credit Amends Loan With Sarepta Therapeutics
IN BRIEF: BioPharma Credit Amends Loan With Sarepta Therapeutics
Read moreTo generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.
Find out MoreIN BRIEF: BioPharma Credit Amends Loan With Sarepta Therapeutics
Read moreIN BRIEF: BioPharma Credit Net Asset Value Dips; Portfolio "Resilient"
Read moreUK EXECUTIVE CHANGE SUMMARY: Cora Hires Ex-Centamin Exploration Exec
Read moreIN BRIEF: BioPharma Credit Secures USD124.5 Million Lexicon Repayment
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIN BRIEF: Biopharma Credit's Portfolio Value To Increase On New Loans
Read moreIN BRIEF: BioPharma Credit To Ink USD156.2 Million From Amicus
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreBioPharma Credit Agrees USD200 Million Credit Facility With JPMorgan
Read moreBioPharma Credit Meets Dividend Target In 2019 As Net Assets Rise
Read moreBioPharma Credit Declares Interim Dividend Of USD0.0303 Per Share
Read moreBioPharma Credit To Provide USD200 Million Loan To Collegium Pharma
Read more(Sharecast News) - Specialist life sciences investor BioPharma Credit has entered into a definitive senior secured term loan agreement with Collegium Pharmaceutical, alongside the BioPharma-V fund, it announced on Friday.
Read moreBioPharma Credit Invests USD82.5 Million In Global Blood Therapeutics
Read moreBiopharma Credit Loans Sarepta Therapeutics USD450 Million
Read more